Last updated: Oct 17, 2026, 6:30 AM UTC
Latest CEO/CFO Sales $25K+
Browse the latest insider trading activity by CEO and CFOs on the sell side with a total transaction value of $25,000 or more, as reported in SEC Form 4 filings. In the most recent filing, Beam Therapeutics Inc.'s CEO reported selling 50,000 BEAM shares at $23.77 each. You can click on the insiders name to view trading activity specfic to them.
These filings are deferred by 6 hours & limited to 50 category trades. Sign up for real time updates and 20 years of data.
View Latest Alerts
Notable Patterns
Latest Cluster Buys
Latest Penny Stock Buys
Biggest Buys This Week
Biggest Buys This Month
Latest Insider Trading - All Filings
Latest Insider Purchases
Latest Insider Purchases $25K+
Latest Insider Purchases $100K+
Latest Officer Purchases $25K+
Latest Officer Purchases $100K+
Latest CEO/CFO Purchases $25K+
Latest CEO/CFO Purchases $100K+
Latest Insider Sales
Latest Insider Sales $25K+
Latest Insider Sales $100K+
Latest Officer Sales $25K+
Latest Officer Sales $100K+
Latest CEO/CFO Sales $25K+
Latest CEO/CFO Sales $100K+
Loading alerts
50 trades of 9763 total
| File Date | Date of Earliest Transaction | Date of Latest Transaction | Ticker Symbol | Company | Insider Name | Insider Title | Buy/Sell | Transaction Count | Shares Transacted | Price | Total Transaction Value | Total Shares Owned After Transaction | Position Size Change | SEC Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-16 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO | Sell | 2 | 50,000 | $23.77 | $1,188,745.00 | 1,047,205 | 4.56% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2025-11-06 | 2025-11-06 | CTMX | Cytomx Therapeutics, Inc. | Mccarthy Sean A. | CEO | Sell | 1 | 101,793 | $4.54 | $461,906.10 | 1,089,684 | 8.54% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-15 | BLLN | Billiontoone, Inc. | Atay Oguzhan | Chairman and CEO | Sell | 8 | 11,000 | $99.14 | $1,090,574.72 | 149,168 | 6.87% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | ANIP | Ani Pharmaceuticals Inc | Lalwani Nikhil | PRESIDENT & CEO | Sell | 1 | 5,400 | $71.89 | $388,206.00 | 333,689 | 1.59% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AIRJ | Airjoule Technologies Corp. | Jore Matthew B | Chief Executive Officer | Sell | 1 | 50,000 | $3.06 | $153,165.00 | 7,698,020 | 0.65% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-14 | RAL | Ralliant Corp | Newcombe Tamara S. | President and CEO | Sell | 1 | 12,936 | $70.58 | $913,022.88 | 246,897 | 4.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | MDT | Medtronic Plc | Martha Geoffrey | Chairman and CEO | Sell | 1 | 50,000 | $95.00 | $4,750,000.00 | 277,866 | 15.25% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-16 | PACS | Pacs Group, Inc. | Murray Jason Hulse | Co-Founder, CEO & Chairman | Sell | 6 | 118,729 | $47.29 | $5,614,667.37 | 54,316,520 | 0.22% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-16 | LIFE | Ethos Technologies Inc. | Colis Peter George | CEO and Secretary | Sell | 7 | 120,000 | $38.39 | $4,607,379.28 | 1,537,360 | 7.24% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | SNPS | Synopsys Inc | Ghazi Sassine | PRESIDENT AND CEO | Sell | 1 | 14,604 | $462.84 | $6,759,359.17 | 76,865 | 15.97% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-16 | 2026-10-15 | 2026-10-15 | MPLT | Maplight Therapeutics, Inc. | Kroeger Christopher A. | Chief Executive Officer | Sell | 1 | 73,691 | $8.08 | $595,423.28 | 1,195,909 | 5.80% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-16 | 2026-10-15 | 2026-10-15 | MPLT | Maplight Therapeutics, Inc. | Gillis Jonathan | CAO and Interim CFO | Sell | 1 | 10,167 | $8.08 | $82,149.36 | 142,315 | 6.67% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AMBQ | Ambiq Micro, Inc. | Esaka Fumihide | Chief Executive Officer | Sell | 4 | 5,000 | $51.00 | $255,017.48 | 443,900 | 1.11% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | GRAL | Grail, Inc. | Ofman Joshua J. | Chief Executive Officer | Sell | 6 | 20,000 | $136.85 | $2,736,944.71 | 342,271 | 5.52% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 12 | 9,500 | $546.65 | $5,193,199.71 | 324,443 | 2.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | MRVL | Marvell Technology, Inc. | Murphy Matthew J | Chairman of the Board and CEO | Sell | 1 | 7,500 | $235.47 | $1,766,025.00 | 768,186 | 0.97% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | HIPO | Hippo Holdings Inc. | Ostergaard Torben | CEO Spinnaker | Sell | 1 | 1,169 | $35.03 | $40,955.21 | 60,655 | 1.89% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | VRSK | Verisk Analytics, Inc. | Mann Elizabeth | Chief Financial Officer | Sell | 1 | 400 | $184.85 | $73,940.00 | 17,584 | 2.22% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | GILD | Gilead Sciences, Inc. | Dickinson Andrew D | Chief Financial Officer | Sell | 1 | 3,000 | $156.22 | $468,660.00 | 161,096 | 1.83% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | BJ | Bj's Wholesale Club Holdings, Inc. | Felice Laura L. | EVP, Chief Financial Officer | Sell | 1 | 8,452 | $104.95 | $887,037.40 | 84,416 | 9.10% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | CSW | Csw Industrials, Inc. | Armes Joseph B | Chairman, President & CEO | Sell | 1 | 1,500 | $287.04 | $430,557.60 | 64,083 | 2.29% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-15 | 2026-10-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | President and CEO | Sell | 1 | 25,000 | $4.22 | $105,600.00 | 627,317 | 3.83% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-16 | 2026-10-14 | 2026-10-15 | FERG | Ferguson Enterprises Inc. /De/ | Murphy Kevin Michael | President & Chief Executive Officer | Sell | 2 | 2,461 | $223.42 | $549,843.55 | 168,440 | 1.44% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-13 | 2026-10-14 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | PRESIDENT AND CEO | Sell | 16 | 20,000 | $257.67 | $5,153,490.49 | 7,461,504 | 0.27% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-14 | 2026-10-15 | BJ | Bj's Wholesale Club Holdings, Inc. | Eddy Robert W. | President & CEO | Sell | 7 | 180,184 | $102.27 | $18,427,591.44 | 258,330 | 41.09% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-13 | 2026-10-13 | BJ | Bj's Wholesale Club Holdings, Inc. | Eddy Robert W. | President & CEO | Sell | 1 | 12,400 | $100.18 | $1,242,232.00 | 266,330 | 4.45% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-13 | 2026-10-15 | IOT | Samsara Inc. | Biswas Sanjit | CHIEF EXECUTIVE OFFICER | Sell | 13 | 263,900 | $41.68 | $10,999,921.59 | 41,000 | 86.55% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-15 | 2026-10-15 | SNEX | Stonex Group Inc. | Smith Philip Andrew | Chief Executive Officer | Sell | 1 | 45,000 | $59.50 | $2,677,486.50 | 738,216 | 5.75% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-13 | 2026-10-13 | RDDT | Reddit, Inc. | Huffman Steve Ladd | CEO & President | Sell | 9 | 17,308 | $158.57 | $2,744,445.64 | 336,432 | 4.89% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-14 | 2026-10-14 | QLYS | Qualys, Inc. | Thakar Sumedh S | CEO & PRESIDENT | Sell | 5 | 3,200 | $190.36 | $609,147.56 | 177,138 | 1.77% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-15 | 2026-10-13 | 2026-10-13 | ARQQ | Arqit Quantum Inc. | Leaver Andrew | Chief Executive Officer | Sell | 1 | 2,573 | $16.40 | $42,207.49 | 53,966 | 4.55% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-14 | 2026-10-14 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 16 | 9,500 | $539.99 | $5,129,873.02 | 324,443 | 2.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-15 | 2026-10-13 | 2026-10-13 | AMKR | Amkor Technology, Inc. | Faust Megan | CFO | Sell | 1 | 1,000 | $46.92 | $46,920.00 | 133,105 | 0.75% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-14 | 2026-10-12 | 2026-10-12 | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | Chief Executive Officer | Sell | 2 | 11,087 | $27.55 | $305,490.35 | 694,908 | 1.57% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-09 | 2026-10-09 | PAYS | Paysign, Inc. | Newcomer Mark | CEO | Sell | 1 | 50,000 | $15.34 | $766,895.00 | 9,113,002 | 0.55% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-13 | 2026-10-13 | DSP | Viant Technology Inc. | Madden Larry | Chief Financial Officer | Sell | 1 | 20,711 | $13.14 | $272,059.70 | 322,000 | 6.04% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-14 | BETA | Beta Technologies, Inc. | Clark Kyle | President and Chief Executive Officer | Sell | 3 | 30,000 | $18.67 | $560,177.00 | 5,085,936 | 0.59% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-14 | 2026-10-14 | FORM | Formfactor Inc | Slessor Mike | CEO | Sell | 3 | 11,098 | $125.20 | $1,389,436.93 | 455,596 | 2.38% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | CRWV | Coreweave, Inc. | Agrawal Nitin | Chief Financial Officer | Sell | 2 | 22,579 | $80.13 | $1,809,260.15 | 110,017 | 17.03% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | BLLN | Billiontoone, Inc. | Atay Oguzhan | Chairman and CEO | Sell | 6 | 19,334 | $94.31 | $1,823,449.79 | 151,835 | 11.30% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-13 | 2026-10-13 | MSFT | Microsoft Corp | Hood Amy | EVP, Chief Financial Officer | Sell | 3 | 7,305 | $545.42 | $3,984,302.99 | 555,396.43 | 1.30% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-13 | 2026-10-13 | AI | C3.Ai, Inc. | Siebel Thomas M | CEO and Chairman of the Board | Sell | 1 | 435,363 | $11.82 | $5,145,076.40 | 722,362 | 37.61% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-13 | 2026-10-13 | VRSN | Verisign Inc/Ca | Bidzos D James | Exec. Chairman, Pres, & CEO | Sell | 5 | 3,300 | $302.85 | $999,403.54 | 375,127.41 | 0.87% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | W | Wayfair Inc. | Shah Niraj | Chief Executive Officer | Sell | 5 | 69,000 | $105.75 | $7,296,706.99 | 222,137 | 23.70% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | XMTR | Xometry, Inc. | Sahni Sanjeev Singh | Chief Executive Officer | Sell | 3 | 1,500 | $108.80 | $163,201.41 | 178,291 | 0.83% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | SIBN | Si-Bone, Inc. | Francis Laura | Chief Executive Officer | Sell | 1 | 38,006 | $20.05 | $762,012.70 | 379,256 | 9.11% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-12 | AI | C3.Ai, Inc. | Lath Hitesh | CHIEF FINANCIAL OFFICER | Sell | 1 | 20,000 | $12.37 | $247,400.00 | 305,250 | 6.15% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-13 | 2026-10-13 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 10 | 9,500 | $545.52 | $5,182,414.18 | 324,443 | 2.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-09 | 2026-10-09 | NCNO | Ncino, Inc. | Desmond Sean | CEO & President | Sell | 1 | 43,992 | $19.90 | $875,440.80 | 1,231,080 | 3.45% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-14 | 2026-10-12 | 2026-10-13 | PLUS | Eplus Inc | Marion Elaine D | CHIEF FINANCIAL OFFICER | Sell | 4 | 5,000 | $96.29 | $481,455.48 | 79,259 | 5.93% | View filing |
Loading alerts